HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilio Cortes-Sanchez Selected Research

Phenobarbital (Luminal)

1/2021PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilio Cortes-Sanchez Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2021
2Neoplasms (Cancer)
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

1Phosphotransferases (Kinase)IBA
01/2021
1TamoxifenFDA LinkGeneric
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021

Therapy/Procedure

3Therapeutics
01/2022 - 01/2021
1Precision Medicine
01/2022
1Drug Therapy (Chemotherapy)
01/2021